Globus Medical Inc - Class A

Research Globus Medical Inc - Class A (GMED) on Bullrun: valuation model: 22.8% undervalued, market cap USD 11.39B, P/E 19.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGMED
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal22.8% undervalued
• Market capUSD 11.39B
• P/E19.5
• Financial periodFY2025
• RevenueUSD 2.94B
• Revenue growth16.7%
• Net incomeUSD 537.87M
• Free cash flowUSD 588.77M
• Gross margin67.4%

Valuation Snapshot

Bullrun's latest valuation model marks Globus Medical Inc - Class A as 22.8% undervalued; latest market cap is USD 11.39B; P/E is 19.5.

About Globus Medical Inc - Class A

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices;

Frequently asked questions

Is Globus Medical Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Globus Medical Inc - Class A as 22.8% undervalued.

What is Globus Medical Inc - Class A's market cap?

Globus Medical Inc - Class A's market capitalization is USD 11.39B.

What is Globus Medical Inc - Class A's P/E ratio?

Globus Medical Inc - Class A's price-to-earnings (P/E) ratio is 19.5.

What does Globus Medical Inc - Class A do?

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.